Indrayani Biotech (BOM:526445) Stock Based Compensation: ₹0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:526445 Indrayani Biotech Ltd BOM:526445
51 GF Score
Price ₹7.86
GF Value ₹41.63
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Indrayani Biotech Stock Based Compensation?

Indrayani Biotech BOM:526445 +4.80% 51 Stock Based Compensation is ₹0 Mil as of Dec. 2025. GuruFocus rates BOM:526445 with a GF Score™ of 51/100 and a GF Value™ of ₹41.63 (Possible Value Trap). The stock has 7 warning signs investors should review.

Indrayani Biotech's Stock Based Compensation for the three months ended in Dec. 2025 was ₹0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was ₹0 Mil.

Indrayani Biotech Stock Based Compensation Related Terms

Indrayani Biotech Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Indrayani Biotech's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indrayani Biotech Stock Based Compensation Chart

Indrayani Biotech Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Indrayani Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:526445
51GF Score
Indrayani Biotech Ltd BOM:526445
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indrayani Biotech Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

What does a Stock Based Compensation of ₹0 Mil mean?
Indrayani Biotech (BOM:526445) has a Stock Based Compensation of ₹0 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Indrayani Biotech and its competitors.
Is Indrayani Biotech's Stock Based Compensation too high?
Indrayani Biotech's current Stock Based Compensation is ₹0 Mil. Overall, Indrayani Biotech has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indrayani Biotech's Stock Based Compensation compare to CTAS and CPRT?
Indrayani Biotech's Stock Based Compensation of ₹0 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Business Services company?
A good Stock Based Compensation depends on the Business Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Indrayani Biotech and its competitors. Indrayani Biotech's current Stock Based Compensation is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indrayani Biotech stock overvalued right now?
Based on GuruFocus' analysis, Indrayani Biotech (BOM:526445) is currently considered Possible Value Trap. The stock's GF Value™ is ₹41.63, compared to a current price of ₹7.86 — trading 81.1% below its estimated fair value. The current Stock Based Compensation is ₹0 Mil. Indrayani Biotech's overall GF Score™ is 51/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Indrayani Biotech (BOM:526445), the current Stock Based Compensation is ₹0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indrayani Biotech (BOM:526445) Overvalued in 2026?

Based on GuruFocus' analysis, Indrayani Biotech stock appears to be undervalued. The current stock price of ₹7.86 is trading 81.1% below its estimated GF Value™ of ₹41.63. GuruFocus considers Indrayani Biotech to be Possible Value Trap.

Key valuation signals for BOM:526445:

  • Stock Based Compensation: ₹0 Mil
  • GF Value™: ₹41.63 vs. price of ₹7.86 (81.1% below fair value)
  • GF Score™: 51/100 with 7 warning signs

No single metric tells the full story. See the BOM:526445 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Indrayani Biotech Business Description

Address Module No. 33, Block 1, 3rd Floor, SIDCO Electronic Complex, Thiru-vi-ka Industrial Estate, Guindy, Chennai, TN, IND, 600032
Indrayani Biotech Ltd operates in the Tri-segment i.e. Foods & Hospitality, Engineering and Healthcare divisions. The company generates its revenue from the sale of food, beverages, and other items; the Sale of Engineering products & Others. The majority of its revenue is generated from the sale of food, beverages, and other items.
51GF Score

Get the complete analysis for BOM:526445

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.86
Price
₹41.63
GF Value